Press release
Melanoma Treatment Market – Global Industry Insights, 2025
Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in the treatment and increase survival rates. According to the American Academy of Dermatology 2015 report, the prevalence of melanoma is increasing and spreads to other body parts as well. As it spreads to other body parts, its treatment becomes much more complex. The rare genetic conditions such as xeroderma pigmentosum also increase the risk of melanoma and it is diagnosed with the biopsy of any skin lesion.Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/719
Melanoma Treatment Market Taxonomy:
The global melanoma treatment market is segmented as follows;
By Melanoma Type;
Cutaneous Melanoma
Mucosal Melanoma
Ocular Melanoma
By Therapy;
Chemotherapy
Immunotherapy
Targeted Therapy
Surgical Treatment
Pharmacological Treatment
Development of new drugs fuels the melanoma treatment market
Several drugs in the market have already received FDA approval for melanoma treatment and some are under development. Drugs such as seviprotimut-L by Polynoma’s, talimogene laherparepvec (T-VEC) by Amgen Inc., and zelboraf, by Roche and Genetech together for the treatment of cutaneous melanoma are under development. Selumetinib is under development by AstraZeneca for the treatment of ocular melanoma. In 2011, Yervoy, a monoclonal antibody drug was developed by Bristol-Myers Squibb for the treatment of melanoma and it is the first drug to receive FDA approval. Immunotherapy drugs include opdivo and keytruda, which got FDA approval and created new opportunities in melanoma treatment market. When chemotherapy fails to deliver results, targeted therapy is used, which include BRAF inhibitors. Targeted therapy has limited side effects in comparison with chemotherapy. According to Cancer Research Institute, in 2016, there were around 76,000 people diagnosed with melanoma in the U.S. The development of novel drugs and combination therapy with limited side effects and better survival rates is expected to fuel the melanoma treatment market growth. The increased focus on personalized medicine with a huge investment in anti-melanoma drugs is expected to create new opportunities in near future. However, high price of combination therapies and clinical trial with side effects act as restraints for the melanoma treatment market.
Developed regions support the growth of melanoma treatment market
Melanoma treatment market, based on geography, is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the melanoma treatment market due to the high prevalence of melanoma in the region along with well-developed healthcare facilities and increased research and development on melanoma drugs. Moreover, reimbursement policy and increase in per capita income are expected to fuel the melanoma treatment market. Europe is the second largest market and is expected to grow significantly in near future due to increase in melanoma cases and development of novel therapies. Asia Pacific is expected to exhibit moderate growth due to fewer cases of skin cancer, lack of awareness, and high cost of melanoma drugs.
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/melanoma-treatment-market-719
Key Players in the Global Melanoma Treatment Market
Some of the key players identified across the value chain of global melanoma treatment market are Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genetech Inc., Novartis AG, Polynoma LLC, AstraZeneca, Amgen Inc., Sanofi, Merck & Co. Inc., and Takeda Pharmaceutical Company.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Melanoma Treatment Market – Global Industry Insights, 2025 here
News-ID: 735397 • Views: …
More Releases from Coherent Market Insights

Alpha 1 Lung Disease Market Thriving with Genetic Disorder Awareness and Targete …
The Alpha 1 Lung Disease industry is undergoing significant transformation with increased research activity and therapeutic advancements targeting genetic deficiencies responsible for this condition. Recent innovations in personalized medicine and enhanced diagnostic capabilities are shaping the competitive landscape, fostering improvements in patient outcomes. The Alpha 1 Lung Disease Market size is estimated to be valued at USD 1.85 billion in 2025 and is expected to reach USD 3.7 billion by…

Real-world Data (RWD) Market Growing with Evidence-Based Healthcare Decisions an …
The Real-world Data (RWD) market has become a pivotal industry segment driven by an unprecedented surge in healthcare digitization, regulatory support for evidence-based research, and the widespread adoption of advanced analytics tools. Its significance in clinical decision-making and drug development processes is rapidly expanding, impacting how treatments and outcomes are evaluated globally. The Global Real-world Data Market size is estimated to be valued at USD 6.8 billion in 2025 and…

Parenteral Packaging Market Booming with Injectable Drug Demand and Sterile Pack …
The Parenteral Packaging Market is witnessing accelerated expansion driven by rising demand for sterile drug delivery solutions and the increasing adoption of biologics and biosimilars worldwide. Advancements in packaging materials and growing regulatory emphasis on patient safety and product integrity have further intensified market dynamics. The Global Parenteral Packaging Market size is estimated to be valued at USD 10.6 billion in 2025 and is expected to reach USD 18.9 billion…

Wound Care Market Expanding with Chronic Wound Management Innovations and Home-B …
The wound care industry has witnessed transformative advancements driven by innovations in biomaterials, advanced dressing technologies, and integration of digital healthcare solutions. As chronic wounds and an aging population escalate global healthcare demands, the market is poised for significant expansion. The Global Wound Care Market size is estimated to be valued at USD 15.8 billion in 2025 and is expected to reach USD 28.5 billion by 2032, exhibiting a compound…
More Releases for Melanoma
Emerging Trends Influencing The Growth Of The Advanced Melanoma Market: Innovati …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Advanced Melanoma Market Size Expected to Be by 2034?
In recent times, the market size of advanced melanoma has witnessed a significant surge. The projections show an increase from $3.77 billion in 2024 to $4.13 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. Contributing…
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period?
The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment…
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market?
The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt…
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market?
The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in…
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• Amgen, Inc.
• Merck & Co., Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Sanofi S.A.
• Qiagen NV
• Sun Pharmaceutical Industries Ltd…
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which…